ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 152 filers reported holding ANI PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 9.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $1,000 | 0.0% | 14 | 0.0% | 0.00% | – |
| Q3 2018 | $1,000 | -66.7% | 14 | -67.4% | 0.00% | – |
| Q2 2018 | $3,000 | 0.0% | 43 | -8.5% | 0.00% | – |
| Q1 2018 | $3,000 | 0.0% | 47 | +11.9% | 0.00% | – |
| Q4 2017 | $3,000 | +50.0% | 42 | 0.0% | 0.00% | – |
| Q3 2017 | $2,000 | 0.0% | 42 | 0.0% | 0.00% | – |
| Q2 2017 | $2,000 | +100.0% | 42 | +180.0% | 0.00% | – |
| Q1 2017 | $1,000 | -92.3% | 15 | -92.5% | 0.00% | -100.0% |
| Q3 2016 | $13,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 326,778 | $20,152,000 | 2.95% |
| Hawk Ridge Capital Management | 188,761 | $11,641,000 | 1.89% |
| Global Alpha Capital Management Ltd. | 169,746 | $10,468,000 | 1.55% |
| Mesirow Financial Investment Management, Inc. | 5,723 | $353,000 | 1.49% |
| 1492 Capital Management LLC | 25,093 | $1,547,000 | 1.37% |
| THB ASSET MANAGEMENT | 91,018 | $5,613,000 | 1.04% |
| Regent Investment Management LLC | 41,329 | $2,549,000 | 0.78% |
| Phocas Financial Corp. | 101,567 | $6,263,000 | 0.75% |
| INVESTMENT COUNSELORS OF MARYLAND LLC | 284,334 | $17,535,000 | 0.75% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 35,500 | $2,189,000 | 0.70% |